ClinicalTrials.gg
Not yet recruitingNCT07945808Updated Nov 18, 2026

Education and Exercise Program for Spinal Health in Women

An interventional study of Spinal Health Education and Exercise Program in Low Back Pain, Neck Pain and Musculoskeletal Pain, sponsored by Acibadem University. Not yet recruiting. Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Acibadem University · Not applicable, Interventional, and Prevention

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

The aim of this study is to evaluate the effects of a 6-week structured education and exercise program on postural awareness, pain beliefs, pain self-efficacy, musculoskeletal symptoms, lower extremity functional performance and quality of life in adult women. The program is delivered within a social responsibility project of the Soroptimist Women's Confederation of Turkey in seven centers in Turkey. All participants receive the same program and are assessed before the program and at the end of week 6.

Read the detailed description

Spinal pain is one of the leading causes of years lived with disability worldwide, and both low back pain and neck pain are more prevalent in women than in men. Exercise, alone or combined with education, has been shown to reduce the risk of low back pain episodes.

Design: Multicenter, single-group, pretest-posttest (quasi-experimental) interventional study. There is no control group and no randomization. The study will be conducted and reported in line with the TREND statement, and the intervention will be described according to the TIDieR checklist.

Setting: The study is carried out within a social responsibility project of the Soroptimist Women's Confederation of Turkey, coordinated by the Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Acibadem Mehmet Ali Aydinlar University, in seven centers (Ankara, Izmir, Bursa, Adana, Tarsus, Eskisehir and Karadeniz Eregli). Assessment and intervention follow the same written protocol, education materials and exercise booklet in all centers, and center investigators receive a common standardization training before the study.

Intervention: Physiotherapists deliver one face-to-face group session per week for 6 weeks (groups of 8-12 women, about 60 minutes: about 20 minutes education and 40 minutes supervised exercise). Education covers spinal anatomy and function, posture and postural awareness, ergonomics and activities of daily living, a biopsychosocial explanation of pain, spinal health across women's life stages, and self-management. Exercises include breathing and spinal mobility, postural awareness, trunk stabilization, strengthening, stretching, functional strength and balance exercises, progressed weekly. Participants are asked to perform the exercises of each week at home at least 3 days per week (about 20-30 minutes) until the next session, guided by an illustrated exercise booklet; adherence is monitored with an exercise diary and session attendance records.

Assessments: Sociodemographic and clinical data, Nordic Musculoskeletal Questionnaire, Postural Awareness Scale (Turkish version), Pain Beliefs Questionnaire, Pain Self-Efficacy Questionnaire, WHOQOL-BREF (Turkish version) and the 30-Second Chair Stand Test are administered face to face at baseline and at week 6. Satisfaction with the program is rated at week 6.

Sample size: As this is a social responsibility project, no a priori sample size calculation was performed; all women who apply during the recruitment period and meet the eligibility criteria will be included (criterion sampling). Approximately 150 women are expected. Effect sizes with 95% confidence intervals and post hoc power will be reported.

Statistical analysis: Pretest and posttest values will be compared with the paired samples t-test or Wilcoxon signed-rank test according to the distribution of the data. Effect sizes (Cohen's d) with 95% confidence intervals will be reported. The significance level is set at p\<0.05.

02

Conditions studied

  • Low Back Pain
  • Neck Pain
  • Musculoskeletal Pain
  • Posture

Keywords

  • spinal health
  • women
  • exercise
  • patient education
  • postural awareness
  • pain beliefs
  • self-efficacy
  • quality of life
03

In context

Low Back Pain

2,929 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

This study's planned enrollment of 150 is above the median of 60 across 2,368 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Acibadem University is the lead sponsor of 222 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 18-65 years
  • Literate and able to communicate in Turkish
  • Able to attend the program sessions regularly for 6 weeks
  • Voluntary participation and signed

Exclusion criteria

Exclusion Criteria:

  • Pregnancy or planning a pregnancy during the study
  • Spinal, hip or knee surgery in the last 6 months
  • History of serious spinal pathology or red flags (, infection, inflammatory rheumatic disease, vertebral fracture, cauda equina symptoms)
  • Spinal pain with radicular signs or progressive neurological deficit
  • Uncontrolled cardiovascular, respiratory or metabolic disease, or exercise restriction by a physician
  • Neurological or orthopedic disease preventing exercise
  • Physiotherapy for the spine or participation in a structured exercise program in the last 3 months
  • Cognitive or psychiatric disorder preventing understanding and completing the questionnaires
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Education and Exercise Program

    All participants receive a 6-week structured spinal health education and exercise program: one supervised group session per week (about 20 minutes education and 40 minutes exercise) plus a home exercise program at least 3 days per week.

    Behavioral: Spinal Health Education and Exercise Program

Interventions

  • BehavioralSpinal Health Education and Exercise Program

    Six weekly face-to-face group sessions (about 60 minutes) delivered by physiotherapists, each including education on spinal health (spinal anatomy and function, posture, ergonomics, biopsychosocial explanation of pain, spinal health across women's life stages, self-management) and progressive exercises (breathing, mobility, postural awareness, trunk stabilization, strengthening, stretching, functional strength and balance). The exercises of each week are performed at home at least 3 days per week (about 20-30 minutes) with an illustrated booklet and an exercise diary.

06

What researchers measure

Primary outcomes

  1. Postural awareness (Postural Awareness Scale, Turkish version)

    The Turkish version of the Postural Awareness Scale includes 11 items rated from 1 (not true about me at all) to 7 (completely true about me); total score ranges from 11 to 77. Higher scores indicate greater postural awareness. Change from baseline to week 6 will be analyzed.

    Time frame: Baseline and week 6

Secondary outcomes

  1. Musculoskeletal symptoms (Nordic Musculoskeletal Questionnaire)

    Presence of pain, ache or discomfort in 9 body regions in the last 12 months and the last 7 days, and activity limitation due to these symptoms in the last 12 months (yes/no for each region).

    Time frame: Baseline and week 6

  2. Pain beliefs (Pain Beliefs Questionnaire)

    12-item questionnaire rated on a 6-point scale (always to never), with organic beliefs and psychological beliefs subscale scores calculated separately.

    Time frame: Baseline and week 6

  3. Pain self-efficacy (Pain Self-Efficacy Questionnaire)

    10 items rated from 0 (not at all confident) to 6 (completely confident); total score ranges from 0 to 60. Higher scores indicate greater pain self-efficacy.

    Time frame: Baseline and week 6

  4. Quality of life (WHOQOL-BREF, Turkish version)

    Physical, psychological, social relationships and environment domain scores (4-20). Higher scores indicate better quality of life.

    Time frame: Baseline and week 6

  5. Lower extremity functional performance (30-Second Chair Stand Test)

    Number of complete sit-to-stand repetitions performed in 30 seconds with arms crossed over the chest. Higher numbers indicate better performance.

    Time frame: Baseline and week 6

  6. Satisfaction with the program

    Single item rated from 1 (not satisfied at all) to 5 (very satisfied).

    Time frame: Week 6

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for May 2027, 5 months later.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 5 months is below that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2026
First posted
Nov 18, 2026
StartEst.
Dec 15, 2026
Primary completionEst.
May 31, 2027
CompletionEst.
Jun 15, 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07945808
Responsible party
Hasan Gerçek (Assistant Professor, Acibadem University) — Principal investigator
First posted
Nov 18, 2026
Start date
Dec 15, 2026 (estimated)
Primary completion
May 31, 2027 (estimated)
Completion
Jun 15, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Hasan Gercek, PhD, PT
Contact
hasan.gercek@acibadem.edu.tr
+90 542 648 84 55
Hasan Gercek, PhD, PT
principal investigator · Acibadem University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion